Application of tissue microarray: Evaluation of the expression of S-100-positive dendritic cells, tumor suppressor gene p63 and tissue inhibitor of metalloproteinase-1 in laryngeal carcinoma

Acta Oto-Laryngologica

Volumn 124, Issue 10, 2004, Pages 1204-1207

  Dong, Pin ^a   Li, Xiaoyan ^a   Zhu, Zhenghua ^a   Yu, Ziwei ^a   Lu, Guangzhong ^a   Sun, Zhenfeng ^a   Wang, Sang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Dendritic cell; Immunohistochemistry; Laryngeal carcinoma; p63 gene; Prognosis; Tissue chip technology; Tissue inhibitor of metalloproteinase 1; Tissue microarray

Indexed keywords

BIOTIN; PEROXIDASE; PROTEIN P63; PROTEIN S 100; STREPTAVIDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; DENDRITIC CELL; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DENDRITIC CELLS; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; S100 PROTEINS; TISSUE ARRAY ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 11144234858     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410017161     Document Type: Article

References (13)

1. Epstein JR, Leung AP, Lee KH, Walt DR. High-density, microsphere-based fiber optic DNA microarrays. Biosens Bioelectron 2003; 18: 541-6.
2. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarray for highthroughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-7.
3. Gregersen PK, Brehrens TW. Fine mapping the phenotype in autoimmune disease: the promise and pitfalls of DNA microarray technologies. Genes Immun 2003; 4: 175-6.
4. Camp RL, Dolled-Filhart M, King BL, Rimm DL. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res 2003; 63: 1445-8.
5. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 1990; 66: 2012-6.
6. Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, et al. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 1007-10.
7. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997; 387: 713-7.
8. Kaelin WG. The P53 gene family. Oncogene 1999; 18: 7701-5.
9. Bates S, Vonsden KH. Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci 1999; 55: 28-37.
10. Pruneri G, Pignataro L, Manzotti M, Carboni N, Ronchetti D, Neri A, et al. p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 downregulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 2002; 82: 1327-34.
11. Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, et al. Combined analysis of studies of the effect of the matrix metalloproteinase inhibitor marimastat on serum tumour markers in advanced cancer: selection of a biologically active and tolerable dose for long term studies. Clin Cancer Res 1998; 4: 1101-9.
12. Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res 1999; 19: 1589-92.
13. Danilewicz M, Sikorska B, Wagrowska-Danilewicz M. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer. Med Sci Monit 2003; 9: 42-7.